Companies: 10,795·Total market cap: $144.5T
Rennova Health, Inc.

Rennova Health, Inc.

RNVAOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4305132
P/E Ratio
52W High$0.0001
52W Low$0.0001
Overview

Rennova Health, Inc. (RNVA) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

RNVA · net income · updated Jun 15, 2026

Core profitability metrics

Net income was −$7.7M for FY2023 (fiscal year ending 2023-12-31), down 134.7% year-over-year. Net profit margin was -41.4%. Based on available data, Rennova Health, Inc. has been profitable since at least 2021.

FY2023 Net Income−$7.7M▼ -134.7% YoY
Trailing 12M (TTM)−$7.7Mtrailing 4 quarters sum
Net Profit Margin-41.4%−$7.7M ÷ $18.7M
YoY Change-134.7%
5-Year CAGRN/AN/A — contains loss years
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 15, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2021

▸ FMP /income-statement · Annual · RNVA net income history · RNVA profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2023Loss−$7.7M▼ 134.7%-41.4%
FY2022Loss−$3.3M▼ 158.8%-25.3%
FY2021★ First Profit$5.6M▲ +130.6%173.9%
FY2020Loss−$18.3M▲ +61.8%-254.7%
FY2019Loss−$48.0M▼ 242.6%-300.1%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Rennova Health, Inc.
Rennova Health, Inc.YOU
RNVA
−$7.7M-134.7%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Rennova Health, Inc. (RNVA) reported net income of −$7.7M for FY2023 (fiscal year ending 2023-12-31), down 134.7% year-over-year. The net profit margin was -41.4% — meaning the company kept $-0.41 of every dollar of revenue as profit.

Based on available data, Rennova Health, Inc. has been profitable since at least 2021. Net income reached a peak of $5.6M in FY2021. Data available for 15 fiscal years.

Rennova Health, Inc.'s net profit margin was -41.4% for FY2023, based on the latest annual results.

Investors sometimes search for "Rennova Health, Inc. net worth" — the company's market capitalization is a separate figure from RNVA net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

RNVA net income · 4 questions

Rennova Health, Inc. is not currently profitable on an annual basis. The company reported a net loss of $7.7M for FY2023.

is RNVA profitabledoes RNVA make a profitRNVA profitabilityRNVA profitable company

Source: FMP /income-statement · GAAP · Rennova Health, Inc. · Rennova Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026